Unmasking cytomegalovirus colitis: a case of haemorrhagic colitis in a patient with chronic myeloid leukaemia on dasatinib

Background: Tyrosine kinase inhibitors (TKIs) are the first-line treatment for chronic myeloid leukaemia (CML) with BCR-ABL1 translocation. Dasatinib, a second-generation TKI, is associated with a wide range of adverse effects such as myelosuppression, pleural effusion, diarrhoea, and haemorrhagic c...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Maria Camila Tole, Nehemias Antonio Guevara, Sangam Sangam, Yemesrach Mekonen, Yevhen Kushnir, Angela Torijano, Ilmana Fulger
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	SMC MEDIA SRL 2026-01-01
Schriftenreihe:	European Journal of Case Reports in Internal Medicine
Schlagworte:	chronic myelogenous leukaemia haemorrhagic colitis dasatinib cytomegalovirus infection
Online-Zugang:	https://www.ejcrim.com/index.php/EJCRIM/article/view/5605
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!